Industry Watch
Association of 37 markers of ultra-processing with all-cause mortality: a prospective cohort study in the UK Biobank
8th October 2025
This study investigated the association between specific markers of ultra-processing (MUPs) and all-cause mortality using a population-based, prospective cohort study which included 186,744 UK Biobank participants between 40 and 75 years old.
The study examined the individual associations of MUPs i.e. flavour, sweetener, emulsifier, and gelling agent with mortality as each may have a different impact on health outcomes.
Can food markets help tackle Glasgow's health crisis?
8th October 2025
Markets which will offer healthy food will be set up in some of the most deprived areas in Glasgow in an effort to address food insecurity and obesity.
The University of Glasgow using a £1m three-year pilot project will investigate why many Glaswegians have a poor diet lacking in high fibre foods, fruit, and vegetables. This will be done along with local groups.
Dr Ada Garcia, who is leading the study, has stated "This has been an underlying issue in Glasgow for years, but there have been a lot of different actions going on trying to tackle it. The problem is not going away though, and we know obesity rates are increasing – so is cardiovascular disease and type 2 diabetes."
NHS inpatient survey shows modest improvements in patients’ overall experiences
24th September 2025
This survey, coordinated by Picker for the Care Quality Commission (CQC), examined patients' experiences of their hospital treatment that involved at least one overnight stay. The survey explored every aspect of their care from referral to after discharge from hospital.
The patients’ overall ratings of their care improved. Patients who rated their care as 9 out of 10 increased from 50.8% to 52.1%. However, 42% of people who had a planned hospital admission stated that they would have liked to have been admitted to hospital earlier. Also, 43% stated that their health became “a bit” or “much worse” whilst on the waiting list.
Skipping breakfast and its wide-ranging health consequences: A systematic review from multiple metabolic disruptions to socioeconomic factors
10th September 2025
The aim of the systematic review was to examine the impact of skipping breakfast across multiple health domains. This included diabetes, regulation of weight, composition of gut microbiome, neurodegenerative diseases, cardiovascular health, cancer, immunity, sleep cycles, psychiatric disorders, bone health, athletic performance, socioeconomic factors, and cognitive function.
The systematic review examined the literature from 2010 to 2025 and it evaluated 66 studies.
Semaglutide cuts risk of heart attack, stroke or death compared to tirzepatide in STEER study
10th September 2025
The aim of the STEER study was to examine the real-world occurrence of major adverse cardiovascular event (MACE) while being treated with semaglutide or tirzepatide for chronic weight management in standard clinical practice in the United States.
Semaglutide 2.4 mg (Wegovy®) showed a 57% greater reduction in the risk of stroke, heart attack, or death from any cause, in people with overweight or obesity and cardiovascular disease who remained on the treatment in comparison to tirzepatide. The result was found to be significant.
